NR1H4 and diabetic kidney disease: Mounting evidence indicates that patients with DKD commonly exhibit gut microbiota dysbiosis, altered bile acid pool composition, and aberrant expression of bile acid receptors—particularly Farnesoid X Receptor (FXR) and Takeda G protein–coupled receptor 5.